Results 151 to 160 of about 20,467 (239)

Somatostatin and somatostatin receptors in retinal diseases [PDF]

, 2000
Averst, E. (Ellen) ter, Baarsma, G.S. (Seerp), Ercoskan, E.M., Hagen, P.M. (Martin) van, Hofland, L.J. (Leo), Kuijpers, R.W.A.M. (Robert), Lamberts, S.W.J. (Steven), Mooy, C.M. (Cornelia)   +7 more
core   +2 more sources

Synergising Macular Function and Structure in Diabetic Macular Oedema to Improve Patient Care: An International Delphi Consensus. [PDF]

Ophthalmol Ther
Dinah C, Chang A, Gabrielle PH, Singh R, Zarranz-Ventura J, Saffar I, Bagijn M, Ambresin A.   +7 more
europepmc   +1 more source

Similar short-term efficacy of oral levosulpiride and intravitreal ranibizumab in patients with diabetic macular oedema. [PDF]

Eye (Lond)
Adán-Castro E, Núñez-Amaro CD, Villarreal J, Islas IH, García-Roa M, López-Star E, García-Franco R, Robles-Osorio ML, Martínez de la Escalera G, Clapp C.   +9 more
europepmc   +1 more source

Differentiating treatment episodes from gaps in eyes with diabetic macular oedema. [PDF]

Br J Ophthalmol
Hashimoto Y, Hunt AR, Silva R, Witmer A, Kheir WJ, Viola F, Arrazola M, Mahgoub MM, Pollreisz A, Harvey Z, Barthelmes D, Gillies MC.   +11 more
europepmc   +1 more source

Intravitreal Ranibizumab Injections Significantly Influence Retinal Venous Calibre in Patients With Diabetic Macular Oedema. [PDF]

J Ophthalmol
Chehade LK, Ali N, Sanfilippo PG, Sandhu SS, Lim LL, Wickremasinghe SS.   +5 more
europepmc   +1 more source

Clinical practice guidelines for the treatment and management of diabetic macular oedema: a systematic review. [PDF]

Eye (Lond)
McAllister M, Ko S, Bawa K, Mearns E, Tabano D, Martinez A, Faux N, Patel S, Spicer G, Lim JI.   +9 more
europepmc   +1 more source

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report. [PDF]

BMJ Open Ophthalmol
Saad A, Plasencia C, Garweg J, Pfister IB, Munk MR, Eandi CM, Zweifel SA, Grimaldi G, Bartolomeo N, Stillenmunkes R, Schild C, Cattaneo J, Gabathuler F, Menghini M, Ambersin A, Froehlich J, Artemiev D, Weinberger A, Mohamed H, Somfai GM, Hatz K.   +20 more
europepmc   +1 more source

Issue Information

Journal of Diabetes Investigation, Volume 17, Issue 5, Page 709-712, May 2026.
wiley   +1 more source

Phase 1 dose-escalation study of IBI324, a VEGF-A/Ang-2 bispecific antibody, for the treatment of diabetic macular oedema. [PDF]

BMJ Open Ophthalmol
Wang Z, Sun J, Liu K, Tao L, Liu Q, Wu M, Lu S, Deng J, Li L, Qian L, Li X, Sun X.   +11 more
europepmc   +1 more source

Beyond the First Year of Intravitreal Faricimab for Diabetic Macular Oedema: A Single-Centre Experience. [PDF]

Cureus
Tsilegeridis-Legeris T, Kenawy N.
europepmc   +1 more source